BenchSci EMET agentic research environment (enterprise agreement)

BenchSci announced a two-year enterprise agreement for argenx scientists to use EMET, its agentic research environment, in preclinical, computational and drug development workflows; argenx is quoted as testing whether it can accelerate preclinical development.